MedTrace Logo

Perfusion Index for Assessing Femoral and Sciatic Nerve Block Success in Lower Extremity Surgery

NCT07507227 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-04-02

No results posted yet for this study

Summary

Peripheral nerve blocks are increasingly used in lower extremity surgery as an alternative to general anesthesia. However, traditional methods used to assess block success, such as sensory and motor testing, are subjective, time-consuming, and dependent on patient cooperation.

The perfusion index (PI), measured non-invasively using pulse oximetry, reflects peripheral perfusion changes associated with sympathetic blockade and may serve as an early indicator of block effectiveness.

This study aims to evaluate whether PI can be used as an early and reliable marker for assessing the success of combined femoral and sciatic nerve block in patients undergoing elective lower extremity surgery.

A total of 80 patients aged 18-65 years with ASA physical status I-III will receive ultrasound- and nerve stimulator-guided combined femoral and sciatic nerve block. Hemodynamic parameters and perfusion-related variables, including PI, capillary refill time, and skin temperature, will be recorded at baseline and at 5, 10, 20, and 30 minutes after block administration.

The results will be compared with traditional sensory and motor block assessments to determine whether PI provides an earlier and objective assessment of block success.

Conditions

  • Peripheral Nerve Block

Interventions

PROCEDURE

Combined Femoral and Sciatic Nerve Block

Ultrasound- and nerve stimulator-guided femoral and sciatic nerve block performed using a mixture of bupivacaine and lidocaine for anesthesia in lower extremity surgery.

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Principal Investigators

  • Berna Kaya Uğur · Gaziantep University Faculty of Medicine

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2018-09-01
Completion
2019-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07507227 on ClinicalTrials.gov